Sutro Biopharma, Inc. (STRO)
NASDAQ: STRO · Real-Time Price · USD
0.7329
-0.0822 (-10.08%)
May 14, 2025, 2:25 PM - Market open
Sutro Biopharma Employees
Sutro Biopharma had 310 employees as of December 31, 2024. The number of employees increased by 8 or 2.65% compared to the previous year.
Employees
310
Change (1Y)
8
Growth (1Y)
2.65%
Revenue / Employee
$214,303
Profits / Employee
-$791,019
Market Cap
61.90M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 94,300 |
Novo Nordisk | 77,349 |
Novartis AG | 75,883 |
Merck & Co. | 75,000 |
STRO News
- 5 days ago - Sutro Biopharma Reports First Quarter 2025 Financial Results and Business Highlights - GlobeNewsWire
- 12 days ago - Sutro Biopharma to Participate in Upcoming Investor Conferences - GlobeNewsWire
- 15 days ago - Sutro Biopharma to Highlight its Next-Generation Exatecan and Dual-Payload ADC Programs in Presentations at AACR 2025 - GlobeNewsWire
- 2 months ago - Sutro Biopharma Presents Data from Dose-Optimization Portion of REFRαME-O1 Trial in Patients with Platinum Resistant Ovarian Cancer at SGO 2025 - GlobeNewsWire
- 2 months ago - Penny Stock Sutro Biopharma Cuts Costs, Refocuses Pipeline - Benzinga
- 2 months ago - Sutro Biopharma Reports Full Year 2024 Financial Results and Business Highlights - GlobeNewsWire
- 2 months ago - Sutro Biopharma Announces Strategic Portfolio Review Resulting in the Prioritization of its Next-Generation ADC Pipeline - GlobeNewsWire
- 2 months ago - Sutro Biopharma to Present at the TD Cowen 45th Annual Health Care Conference - GlobeNewsWire